0
Skip to Content
Controlled Substance Consulting
Controlled Substance Consulting
Todd Prough, Ph.D. 1/15/25 Todd Prough, Ph.D. 1/15/25

DEA’s New Proposed Telemedicine Regulations

Provide for a Special Registration (and Other Rules) for Telemedicine

Read More
Todd Prough, Ph.D. 5/20/24 Todd Prough, Ph.D. 5/20/24

DEA to Reschedule Marijuana?

Read More
Todd Prough, Ph.D. 4/12/24 Todd Prough, Ph.D. 4/12/24

Prescribing "Red Flag" Analysis

Read More
Todd Prough, Ph.D. 11/13/23 Todd Prough, Ph.D. 11/13/23

DEA Extends Telemedicine Flexibilities Until December 2024

Read More
Todd Prough, Ph.D. 9/29/23 Todd Prough, Ph.D. 9/29/23

Consulting Firm McKinsey Agrees to Pay $207 Million for its Role in the Opioid Epidemic

Read More
Todd Prough, Ph.D. 6/8/23 Todd Prough, Ph.D. 6/8/23

Will the Death of the “X-waiver” Result in Enhanced Treatment for Opioid Use Disorder?

Read More
Todd Prough, Ph.D. 6/8/23 Todd Prough, Ph.D. 6/8/23

Recent $230 Million Walgreens Settlement Highlights the Need for Companies’ Robust Compliance Programs

A compliance program is key for harm reduction.

Read More